PHARMACEUTICAL FORMULATION BASEDON 4-HYDROXY-2-METHYL-2H-1,2-BENZOTHIAZINE-3-/N-2-PYRIDYLCARBOXAMIDE/ -1,1-DIOXIDE

摘要

The drug agent is applied in humane medicine for treatment of rheumatic diseases, chronic polyarthrites, degenerative arthroses, etc. and has an enhanced solvency, reduced ulcerogenic action and an expressed hepatoprotective effect. It contains in weight p. piroxicam 0.005-0.030 and glycine 0.005-0.030.